A20 (TNFAIP3) is a protein that is involved in the negative feedback regulation of NF-κB signaling in response to specific proinflammatory stimuli in different cell types and has been suggested as a susceptibility gene for rheumatoid arthritis. To define the contribution of A20 to rheumatoid arthritis pathology, we generated myeloid-specific A20-deficient mice and show that specific ablation of Tnfaip3 in myeloid cells results in spontaneous development of a severe destructive polyarthritis with many features of rheumatoid arthritis. Myeloid-A20-deficient mice have high levels of inflammatory cytokines in their serum, consistent with a sustained NF-κB activation and higher TNF production by macrophages. Destructive polyarthritis in myeloid ...
A20 is a potent anti-inflammatory molecule, and mutations in TNFAIP3, the gene encoding A20, are ass...
A20 (also known as TNFAIP3) is a potent anti-inflammatory signalling molecule that restricts multipl...
Systemic autoinflammatory diseases are driven by abnormal activation of innate immunity(1). Herein w...
A20 (TNFAIP3) is a protein that is involved in the negative feedback regulation of NF-kappa B signal...
These authors contributed equally to this work. Rheumatoid arthritis (RA) is a chronic autoinflammat...
The anti-inflammatory protein A20 serves as a critical brake on NF-kappa B signaling and NF-kappa B-...
Deficiency in the deubiquitinating enzyme A20 causes severe inflammation in mice, and impaired A20 f...
Deficiency in the deubiquitinating enzyme A20 causes severe inflammation in mice, and impaired A20 f...
Objectives: A20 is an important endogenous regulator of inflammation. Single nucleotide polymorphism...
Objectives: A20 is an important endogenous regulator of inflammation. Single nucleotide polymorphism...
Abstract A20 serves as a critical brake on NF-κB-dependent inflammation. In humans, polymorphisms in...
A20 [also known as TNFAIP3 (tumour necrosis factor a-induced protein 3)] restricts and terminates in...
The ubiquitin-editing protein A20 (TNFAIP3) is a key player in termination of NF-κB signaling, and t...
Nuclear factor (NF)-kappa B has an important role in immunity and inappropriate NF-kappa B activity ...
Immune cell activation is a stringently regulated process, as exaggerated innate and adaptive immune...
A20 is a potent anti-inflammatory molecule, and mutations in TNFAIP3, the gene encoding A20, are ass...
A20 (also known as TNFAIP3) is a potent anti-inflammatory signalling molecule that restricts multipl...
Systemic autoinflammatory diseases are driven by abnormal activation of innate immunity(1). Herein w...
A20 (TNFAIP3) is a protein that is involved in the negative feedback regulation of NF-kappa B signal...
These authors contributed equally to this work. Rheumatoid arthritis (RA) is a chronic autoinflammat...
The anti-inflammatory protein A20 serves as a critical brake on NF-kappa B signaling and NF-kappa B-...
Deficiency in the deubiquitinating enzyme A20 causes severe inflammation in mice, and impaired A20 f...
Deficiency in the deubiquitinating enzyme A20 causes severe inflammation in mice, and impaired A20 f...
Objectives: A20 is an important endogenous regulator of inflammation. Single nucleotide polymorphism...
Objectives: A20 is an important endogenous regulator of inflammation. Single nucleotide polymorphism...
Abstract A20 serves as a critical brake on NF-κB-dependent inflammation. In humans, polymorphisms in...
A20 [also known as TNFAIP3 (tumour necrosis factor a-induced protein 3)] restricts and terminates in...
The ubiquitin-editing protein A20 (TNFAIP3) is a key player in termination of NF-κB signaling, and t...
Nuclear factor (NF)-kappa B has an important role in immunity and inappropriate NF-kappa B activity ...
Immune cell activation is a stringently regulated process, as exaggerated innate and adaptive immune...
A20 is a potent anti-inflammatory molecule, and mutations in TNFAIP3, the gene encoding A20, are ass...
A20 (also known as TNFAIP3) is a potent anti-inflammatory signalling molecule that restricts multipl...
Systemic autoinflammatory diseases are driven by abnormal activation of innate immunity(1). Herein w...